← Back to Search

Diagnostic Test

low dose CT for Tumors

N/A
Waitlist Available
Led By Anna Narezkina, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after completion of chemotherapy
Awards & highlights

Study Summary

This trial will test a new low-dose CT scan protocol to see if it can detect early signs of heart damage in cancer patients receiving anthracycline chemotherapy.

Eligible Conditions
  • Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after completion of chemotherapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months after completion of chemotherapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
cardiomyopathy
Secondary outcome measures
Change in CT-based left ventricular strain parameters
Change in echocardiographic left ventricular ejection fraction
Change in left ventricular global longitudinal strain based on echocardiography

Trial Design

1Treatment groups
Experimental Treatment
Group I: CT monitoring armExperimental Treatment1 Intervention
18-75 year old patients with newly-diagnosed cancer, scheduled to undergo anthracycline-based chemotherapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
low dose CT
2018
N/A
~20

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,520,905 Total Patients Enrolled
Anna Narezkina, MD5.02 ReviewsPrincipal Investigator - UCSD
University of California, San Diego
5Patient Review
UPDATE- Dr. Narezkina goes above and beyond. She listens attentively, takes her time with examinations, and makes referrals to other specialists when necessary. I never feel rushed when I'm with her.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity
Anna Narezkina 2018. "Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03553654.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top